Patients received 20,000 IU of epoetin alfa subcutaneously every 2 wk for up to 27 wk, with dosage adjustments permitted after 4 wk of treatment.

• 病人每两周接受1次重组人红细胞生成素皮下注射，直到第27周，在用药第4周后允许对用药量进行调整。